secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2023-05-24T23:59:59+00:00
Accession:  0001654954-23-007162
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech CFO to retire July 15; shareholders approve share increase for equity plan
--------------------------------------------------------------------------------

- CFO Kathi Niffenegger to retire effective July 15, 2023; will remain as advisor and on subsidiary board.
- Shareholders approved amending 2019 Equity Incentive Plan to increase shares available by 1,380,000.
- All seven director nominees elected at annual meeting with 7.06-7.26M votes each.
- Advisory vote on executive compensation passed with 6.55M for, 0.55M against.
- Appointment of MNP LLP as independent auditor approved with 10.23M for, 0.53M withheld.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000165495423007162/0001654954-23-007162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000165495423007162/edsa_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-007162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer